Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ADMA
CLDX
Add up to 3 more stocks
ADMA
ADMA Biologics, Inc.
+0.51%
$10.16+0.05Delayed quote: Oct 6, 2026, 1:35 PM EDT
Market Cap
$2.36B
52W Range
$7.21 - $25.67
CLDX
Celldex Therapeutics, Inc.
-4.79%
$31.03-1.56Delayed quote: Oct 6, 2026, 1:35 PM EDT
Market Cap
$2.06B
52W Range
$22.10 - $45.14
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 14.52 | N/A |
| Forward P/E | 12.76 | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 5.77 | 2.89 |
| P/S Ratio | 4.60 | 18434.72 |
| P/FCF Ratio | 20.22 | N/A |
| EV/EBITDA | 10.72 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 64.7% | 100.0% |
| Operating Margin | 42.3% | -19160.0% |
| Net Margin | 33.0% | -268385.7% |
| ROE | 41.4% | -42.1% |
| ROA | 24.7% | -38.4% |
| ROIC | 27.6% | -45.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 6.97 | 11.82 |
| Quick Ratio | 3.81 | 11.82 |
| Debt/Equity | 0.50 | 0.01 |
| Interest Coverage | 26.93 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.